Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...
Even gene drives aimed at controlling malaria-carrying mosquitoes rely on CRISPR’s precision. Among CRISPR’s many variants, the compact Type V Cas12 enzymes—key players in genome editing, diagnostics, ...
A man with type 1 diabetes has become the first patient to produce his own insulin after receiving genetically engineered cell transplants, without needing drugs to prevent rejection. The case, ...
CRISPR Therapeutics AG is a long-term buy despite slow Casgevy uptake. Click for my updated look at CRSP earnings and the ...
The race to advance gene editing tech continues, spurred on by starry-eyed Silicon Valley investors, entrepreneurs and even ...
Turning genes on and off is like flipping a light switch, controlling whether genes in a cell are active. When a gene is ...
That’s why a team from UC San Diego in La Jolla set out with Yale University researchers to develop a new system for gene ...
Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds ...